Stability of sulfadiazine sugar-free oral suspensions for the treatment of congenital toxoplasmosis. Braz. J. Pharm. Sci. [Internet]. 2023 Nov. 3 [cited 2024 Dec. 26];59. Available from: https://revistas.usp.br/bjps/article/view/230989